New, rapid method to quantitively screen bispecific antibodies
Discover how using Protein A and His1K biosensors can reduce the time of screening for bispecific antibodies
Discover how using Protein A and His1K biosensors can reduce the time of screening for bispecific antibodies
Consistent, high performance to surpass regulatory limits. The perfect addition to your laboratory.
Join the CEO of MicrosensDx, Simon Walker, for a Q&A surrounding his collaboration with The Mayr Group at Imperial College London to develop a new sepsis test
QuantiFERON-TB Gold Plus remains crucial for the detection of latent tuberculosis infection, aiding in breaking the cycle of disease transmission
New automations in liquid biopsy research hold great promise for bringing us even closer to fully realizing its clinical utility in monitoring cancer from diagnosis through to remission
As concerns about PFAS health risks rise, advancements in chromatography are transforming our understanding of these persistent chemicals. Explore how innovative techniques enhance detection and analysis, paving the way for safer environments and better public health.
In this guest editorial, BioPhorum explores potential improvements to overcome the issues associated with the developing guidance and standardization for the cell, gene and RNA therapy field
Discover how ÄKTA™ chromatography systems automate and enhance the efficiency, reproducibility, and scalability of protein purification workflows
Discover how Siemens Healthineers is breaking down barriers and making automation more accessible, efficient, and beneficial for clinical labs of all sizes
From rapid TB diagnostics to genomic breakthroughs, this Lab Week spotlight reveals how a dedicated team in Djibouti is transforming public health — one test at a time
Explore innovations and tools for clinical labs shaping the future of sepsis management, clinical mass spec, anticoagulant diagnostics, and more
Take advantage of the next generation of combined GC-MS-IRMS
Explore how CLINICAL24 Ambassador, Dr. Vasiliki E. Kalodimou, is leveraging flow cytometry to revolutionize treatments with stem cells and regenerative medicine
AMSBIO's new range avoid the need to source an expensive therapeutic product and enable fast and inexpensive assay development